Evaluation of Non-Invasive Gargle Lavage Sampling for the Detection of SARS-CoV-2 Using rRT-PCR or Antigen Assay.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
19 12 2022
Historique:
received: 07 11 2022
revised: 09 12 2022
accepted: 17 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused considerable disruption worldwide. For efficient SARS-CoV-2 detection, new methods of rapid, non-invasive sampling are needed. This study aimed to investigate the stability of SARS-CoV-2 in a novel medium for gargle-lavage (GL) self-sampling and to compare the performance of SARS-CoV-2 detection in paired self-collected GL and clinician-obtained nasopharyngeal swab (NPS) samples. The stability study for SARS-CoV-2 preservation in a novel medium was performed over 14 days (4 °C, 24-27 °C, and 37 °C). In total, 494 paired GL and NPS samples were obtained at the University Hospital in Olomouc in April 2021. SARS-CoV-2 detection in paired samples was performed with a SARS-CoV-2 Nucleic Acid Detection Kit (Zybio, Chongqing Municipality, Chongqing, China), an Elecsys

Identifiants

pubmed: 36560833
pii: v14122829
doi: 10.3390/v14122829
pmc: PMC9786102
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Clin Infect Dis. 2020 Jul 28;71(15):793-798
pubmed: 32221523
Emerg Infect Dis. 2004 Jul;10(7):1213-9
pubmed: 15324540
J Clin Med. 2021 Dec 08;10(24):
pubmed: 34945047
Infect Control Hosp Epidemiol. 2021 Nov;42(11):1340-1344
pubmed: 33436122
Microorganisms. 2021 Aug 10;9(8):
pubmed: 34442779
Diagnostics (Basel). 2022 Jan 04;12(1):
pubmed: 35054277
Int J Antimicrob Agents. 2020 May;55(5):105951
pubmed: 32234466
Clin Infect Dis. 2020 Jul 28;71(15):841-843
pubmed: 32047895
Int J Infect Dis. 2021 Sep;110:261-266
pubmed: 34302962
BMJ. 2021 Jul 27;374:n1676
pubmed: 34315770
Clin Chem Lab Med. 2020 Jun 25;58(7):1070-1076
pubmed: 32172228
Diagn Microbiol Infect Dis. 2022 Feb;102(2):115566
pubmed: 34781164
J Clin Microbiol. 2005 May;43(5):2444-8
pubmed: 15872279
Lancet Reg Health Eur. 2021 Jun;5:100086
pubmed: 34396360
Clin Chim Acta. 2020 Jun;505:172-175
pubmed: 32156607
N Engl J Med. 2020 May 28;382(22):e76
pubmed: 32302471
Microbiol Spectr. 2021 Sep 3;9(1):e0036121
pubmed: 34259547
J Clin Virol. 2020 Aug;129:104500
pubmed: 32585619
Lancet Infect Dis. 2020 Apr;20(4):411-412
pubmed: 32105638
Clin Infect Dis. 2020 Jul 28;71(15):893-894
pubmed: 32241023
Sci Rep. 2022 Mar 8;12(1):3706
pubmed: 35260654
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32317257
BMC Infect Dis. 2021 Aug 10;21(1):798
pubmed: 34376187
J Mol Diagn. 2021 Jan;23(1):3-9
pubmed: 33217552
J Clin Med. 2021 Apr 02;10(7):
pubmed: 33918294
Indian J Med Res. 2020 Jul & Aug;152(1 & 2):77-81
pubmed: 32820725
J Virol Methods. 2021 Sep;295:114184
pubmed: 34029634
Clin Chim Acta. 2021 Jun;517:54-59
pubmed: 33626369
J Clin Microbiol. 2020 Aug 24;58(9):
pubmed: 32636214
J Clin Microbiol. 2021 Mar 19;59(4):
pubmed: 33514627
Lancet Infect Dis. 2021 Sep;21(9):e290-e295
pubmed: 33636148

Auteurs

Ondrej Bouska (O)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.

Hana Jaworek (H)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.
Laboratory of Experimental Medicine, University Hospital Olomouc, 775 15 Olomouc, Czech Republic.

Vladimira Koudelakova (V)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.
Laboratory of Experimental Medicine, University Hospital Olomouc, 775 15 Olomouc, Czech Republic.

Katerina Kubanova (K)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.

Petr Dzubak (P)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.
Laboratory of Experimental Medicine, University Hospital Olomouc, 775 15 Olomouc, Czech Republic.
Cancer Research Czech Republic, 779 00 Olomouc, Czech Republic.

Rastislav Slavkovsky (R)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.

Branislav Siska (B)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.

Petr Pavlis (P)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.

Jana Vrbkova (J)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.

Marian Hajduch (M)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.
Laboratory of Experimental Medicine, University Hospital Olomouc, 775 15 Olomouc, Czech Republic.
Cancer Research Czech Republic, 779 00 Olomouc, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH